Animal Health Production and Hygiene 2146-7269 2687-5330 Aydın Adnan Menderes Üniversitesi 10.53913/aduveterinary.1736811 Veterinary Sciences (Other) Veteriner Bilimleri (Diğer) Oral Vaccines: Recent Advances in Veterinary Medicine Oral Aşılar: Veteriner Alanda Son Gelişmeler https://orcid.org/0000-0001-5111-8656 Kırkan Şükrü AYDIN ADNAN MENDERES ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ, KLİNİK ÖNCESİ BİLİMLERİ BÖLÜMÜ, VETERİNERLİK MİKROBİYOLOJİSİ ANABİLİM DALI https://orcid.org/0009-0000-0152-0153 Polat Ece Gülşah ADNAN MENDERES ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ ENSTİTÜSÜ 03 30 2026 15 1 07 07 2025 09 29 2025 Copyright © 2012, Animal Health Production and Hygiene 2012 Animal Health Production and Hygiene

Oral vaccine technologies offer significant advantages in veterinary applications by having the potential to simultaneously induce local and systemic immune responses in the gastrointestinal mucosa, going beyond traditional injection methods. Their low cost within the food production chain, elimination of needle use, and ability to immunize large animal populations en masse confer particular benefits under field conditions. Antigens transported to the gut‐associated lymphoid tissue via M cells trigger secretory IgA and systemic IgG production, thereby reinforcing mucosal barrier integrity and promoting the formation of immunological memory. This review will examine the fundamental characteristics of oral vaccines used in veterinary medicine, their immune mechanisms, and the factors influencing these mechanisms. Oral and injectable vaccines will be compared to elucidate their advantages and disadvantages. Additionally, strategies for the design and distribution of oral vaccines developed for animals and the challenges encountered throughout this process will be discussed. Finally, the current developments in this field will be reviewed.

Oral aşı teknolojileri, gastrointestinal mukozada hem lokal hem de sistemik bağışıklık yanıtlarını eş zamanlı olarak indükleyebilme potansiyeliyle, veteriner uygulamalarda geleneksel enjeksiyon yöntemlerinin ötesine geçen önemli avantajlar sunmaktadır. Gıda zincirindeki düşük maliyet, iğne kullanımının ortadan kalkması ve geniş hayvan popülasyonlarının kitlesel bazda aşılanabilmesi, özellikle saha koşullarında büyük fayda sağlamaktadır. M-hücreleri aracılığıyla GALT’a aktarılan antijenler, salgısal IgA ve sistemik IgG üretimini tetikleyerek mukozal bariyer bütünlüğünü güçlendirirken, immün hafıza oluşumunu da destekler. Bu derlemede veteriner hekimlik alanında kullanılan oral aşıların temel özellikleri, immün mekanizmaları ve bu mekanizmayı etkileyen faktörler incelenecek, oral ve enjeksiyon aşıları karşılaştırılarak bu aşıların avantaj ve dezavantajları ortaya konacaktır. Aynı zamanda hayvanlar için geliştirilen oral aşıların tasarım ve dağıtımındaki stratejilerin tartışılması ve tüm bu süreçte karşılaşılan zorlukların ortaya konması amaçlanmıştır. Son olarak, bu alandaki güncel gelişmeler gözden geçirilecektir.

 Delivery system M cell targeting Mucosal immunity Nanoparticle Veterinary oral vaccine M hücre hedefleme mukozal bağışıklık nanopartikül taşıyıcı sistem veteriner oral aşı Abdelaziz, K., Helmy, Y. A., Yitbarek, A., Hodgins, D. C., Sharafeldin, T. A., & Selim, M. S. (2024). Advances in poultry vaccines: leveraging biotechnology for improving vaccine development, stability, and delivery. Vaccines, 12(2), 134. https://doi.org/10.3390/ vaccines12020134 Acevedo-Villanueva, K., Akerele, G., Al-Hakeem, W., Adams, D., Gourapura, R., & Selvaraj, R. (2022). Immunization of broiler chickens with a killed chitosan nanoparticle Salmonella vaccine decreases Salmonella enterica serovar enteritidis load. Frontiers in Physiology, 13, 920777. https://doi.org/10.3389/ fphys.2022.920777 Agirman, G., Yu, K. B., & Hsiao, E. Y. (2021). Signaling inflammation across the gut-brain axis. Science, 374(6571), 1087-1092. https:// doi.org/10.1126/science.abi6087 Azman, A. S., Luquero, F. J., Ciglenecki, I., Grais, R. F., Sack, D. A., & Lessler, J. (2015). The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study. PLoS Medicine, 12(8), e1001867. https://doi.org/10.1371/journal. pmed.1001867 Bachmann, M. F., & Jennings, G. T. (2010). Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nature Reviews Immunology, 10(11), 787-796. https://doi.org/10.1038/nri2868 Bauer, G. (2021). The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS- CoV-2. International Journal of Infectious Diseases, 106, 61-64. https://doi.org/10.1016/j.ijid.2021.01.061 Betancor, M., Moreno-Martínez, L., López-Pérez, Ó., Otero, A., Hernaiz, A., Barrio, T., ... & Martín-Burriel, I. (2021). Therapeutic Assay with the Non-toxic C-Terminal fragment of tetanus toxin (TTC) in transgenic murine models of prion disease. Molecular Neurobiology, 58, 5312-5326. https://doi.org/10.1007/s12035- 021-02489-5 Blume, S., & Geesink, I. (2000). A brief history of polio vaccines. Science, 288(5471), 1593-1594. https://doi.org/10.1126/ science.288.5471.1593 Brandtzaeg, P. (2010). Function of mucosa-associated lymphoid tissue in antibody formation. Immunological Investigations, 39(4-5), 303- 355. https://doi.org/10.3109/08820131003680369 Cao, P., Xu, Z. P., & Li, L. (2022). Tailoring functional nanoparticles for oral vaccine delivery: Recent advances and future perspectives. Composites Part B: Engineering, 236, 109826. https://doi. org/10.1016/j.compositesb.2022.109826 Cascio, V., Gittings, D., Merloni, K., Hurton, M., Laprade, D., & Austriaco, N. (2013). S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death. BMC Microbiology, 13, 1-11. https://doi.org/10.1186/1471-2180-13-35 Chen, K., & Cerutti, A. (2010). Vaccination strategies to promote mucosal antibody responses. Immunity, 33(4), 479-491. https:// doi.org/10.1016/j.immuni.2010.09.013 External Link Chen, X., Chen, X., Qiu, S., Hu, Y., Jiang, C., Wang, D., ... & Li, X. (2014). Effects of epimedium polysaccharide-propolis flavone oral liquid on mucosal immunity in chickens. International Journal of Biological Macromolecules, 64, 6-10. https://doi.org/10.1016/j. ijbiomac.2013.11.015 Chiu, C., & Openshaw, P. J. (2015). Antiviral B cell and T cell immunity in the lungs. Nature Immunology, 16(1), 18-26. https://doi. org/10.1038/ni.3056 Clements, J. D., & Norton, E. B. (2018). The mucosal vaccine adjuvant LT (R192G/L211A) or dmLT. MSphere, 3(4), 10-1128. https://doi. org/10.1128/msphere.00215-18 Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012). PLGA-based nanoparticles: an overview of biomedical applications. Journal of Controlled Release, 161(2), 505-522. https://doi.org/10.1016/j.jconrel.2012.01.043 Dempsey, E., & Corr, S. C. (2022). Lactobacillus spp. for gastrointestinal health: current and future perspectives. Frontiers in Immunology, 13, 840245. https://doi.org/10.3389/fimmu.2022.840245 Díaz Dinamarca, D. A., Salazar, M. L., Castillo, B. N., Manubens, A., Vasquez, A. E., Salazar, F., & Becker, M. I. (2022). Protein-based adjuvants for vaccines as immunomodulators of the innate and adaptive immune response: Current knowledge, challenges, and future opportunities. Pharmaceutics, 14(8), 1671. https://doi. org/10.3390/pharmaceutics14081671 Ding, C., Ma, J., Dong, Q., & Liu, Q. (2018). Live bacterial vaccine vector and delivery strategies of heterologous antigen: a review. Immunology Letters, 197, 70-77. https://doi.org/10.1016/j. imlet.2018.03.006 Dwivedy, A., & Aich, P. (2011). Importance of innate mucosal immunity and the promises it holds. International Journal of General Medicine, 299-311. https://doi.org/10.2147/IJGM.S17525 Faber, M., Dietzschold, B., & Li, J. (2009). Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife. Zoonoses and Public Health, 56(6-7), 262-269. https:// doi.org/10.1111/j.1863-2378.2008.01215.x Freytag, L. C., & Clements, J. D. (2005). Mucosal adjuvants. Vaccine, 23(15), 1804-1813. https://doi.org/10.1016/j.vaccine.2004.11.010 Galen, J. E., Pasetti, M. F., Tennant, S., Ruiz-Olvera, P., Sztein, M. B., & Levine, M. M. (2009). Salmonella enterica serovar Typhi live vector vaccines finally come of age. Immunology & Cell Biology, 87(5), 400-412. https://doi.org/10.1038/icb.2009.31 Heim, J. B., Hodnik, V., Heggelund, J. E., Anderluh, G., & Krengel, U. (2019). Crystal structures of cholera toxin in complex with fucosylated receptors point to importance of secondary binding site. Scientific Reports, 9(1), 12243. https://doi.org/10.1038/ s41598-019-48579-2 Hilligan, K. L., & Ronchese, F. (2020). Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses. Cellular & Molecular Immunology, 17(6), 587-599. https://doi.org/10.1038/ s41423-020-0465-0 Howlader, D. R., Koley, H., Sinha, R., Maiti, S., Bhaumik, U., Mukherjee, P., & Dutta, S. (2018). Development of a novel S. Typhi and Paratyphi A outer membrane vesicles based bivalent vaccine against enteric fever. PLoS One, 13(9), e0203631. https://doi.org/10.1371/journal. pone.0203631 Huang, M., Zhang, M., Zhu, H., Du, X., & Wang, J. (2022). Mucosal vaccine delivery: A focus on the breakthrough of specific barriers. Acta Pharmaceutica Sinica B, 12(9), 3456-3474. https://doi. org/10.1016/j.apsb.2022.07.002 Kawamura, Y. I., Kawashima, R., Shirai, Y., Kato, R., Hamabata, T., Yamamoto, M., ... & Dohi, T. (2003). Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-κB translocation. European Journal of Immunology, 33(11), 3205-3212. https://doi.org/10.1002/eji.200324135 Kwong, K. W. Y., Xin, Y., Lai, N. C. Y., Sung, J. C. C., Wu, K. C., Hamied, Y. K., ... & Lam, D. M. K. (2023). Oral Vaccines: A Better Future of Immunization. Vaccines, 11(7), 1232. https://doi.org/10.3390/ vaccines11071232 Li, F., Wang, X., Ma, R., Wu, W., Teng, F., Cheng, X., ... & Li, Y. (2021). Oral immunization with Lactobacillus casei expressing the porcine circovirus type 2 Cap and LTB induces mucosal and systemic antibody responses in mice. Viruses, 13(7), 1302. https://doi. org/10.3390/v13071302 Liu, Y., Lam, D. M. K., Luan, M., Zheng, W., & Ai, H. (2024). Recent development of oral vaccines. Experimental and Therapeutic Medicine, 27(5), 223. https://doi.org/10.3892/etm.2024.12511 Lund, F. E., & Randall, T. D. (2010). Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nature Reviews Immunology, 10(4), 236-247. https://doi.org/10.1038/nri2729 Mathiesen, G., Øverland, L., Kuczkowska, K., & Eijsink, V. G. (2020). Anchoring of heterologous proteins in multiple Lactobacillus species using anchors derived from Lactobacillus plantarum. Scientific Reports, 10(1), 9640. https://doi.org/10.1038/s41598- 020-66531-7 Mukherjee, A., Bisht, B., Dutta, S., & Paul, M. K. (2022). Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy. Acta Pharmacologica Sinica, 43(11), 2759-2776. https://doi.org/10.1038/s41401-022- 00902-w Oh, S. H., Kim, S. H., Jeon, J. H., Kim, E. B., Lee, N. K., Beck, S., ... & Kang, S. K. (2021). Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route. Vaccine, 39(30), 4072-4081. https://doi.org/10.1016/j.vaccine.2021.06.010 Pavot, V., Rochereau, N., Genin, C., Verrier, B., & Paul, S. (2012). New insights in mucosal vaccine development. Vaccine, 30(2), 142-154. https://doi.org/10.1016/j.vaccine.2011.11.003 Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021). Emerging concepts in the science of vaccine adjuvants. Nature Reviews Drug Discovery, 20(6), 454-475. https://doi.org/10.1038/s41573-021- 00163-y Ramirez, J. E. V., Sharpe, L. A., & Peppas, N. A. (2017). Current state and challenges in developing oral vaccines. Advanced Drug Delivery Reviews, 114, 116-131. https://doi.org/10.1016/j.addr.2017.04.008 Rogers, A. W., Tsolis, R. M., & Bäumler, A. J. (2021). Salmonella versus the Microbiome. Microbiology and Molecular Biology Reviews, 85(1), 10-1128. https://doi.org/10.1128/mmbr.00027-19 Rogier, E. W., Frantz, A. L., Bruno, M. E., & Kaetzel, C. S. (2014). Secretory IgA is concentrated in the outer layer of colonic mucus along with gut bacteria. Pathogens, 3(2), 390-403. https://doi.org/10.3390/ pathogens3020390 Saleh, S., Van Puyvelde, S., Staes, A., Timmerman, E., Barbé, B., Jacobs, J., ... & Deborggraeve, S. (2019). Salmonella Typhi, Paratyphi A, Enteritidis and Typhimurium core proteomes reveal differentially expressed proteins linked to the cell surface and pathogenicity. Plos Neglected Tropical Diseases, 13(5), e0007416. https://doi. org/10.1371/journal.pntd.0007416 Setlow, P. (2014). Germination of spores of Bacillus species: what we know and do not know. Journal of Bacteriology, 196(7), 1297-1305. https://doi.org/10.1128/jb.01455-13 Smreczak, M., Orłowska, A., Müller, T., Freuling, C. M., Kawiak- Sadurska, M., & Trębas, P. (2022). Vaccine-induced rabies in a red fox in Poland. Journal of Veterinary Research, 66(4), 473. https:// doi.org/10.2478/jvetres-2022-0065 Srivastava, V., Nand, K. N., Ahmad, A., & Kumar, R. (2023). Yeast- based virus-like particles as an emerging platform for vaccine development and delivery. Vaccines, 11(2), 479. https://doi. org/10.3390/vaccines11020479 Sung, J. C. C., Lai, N. C. Y., Wu, K. C., Choi, M. C., Ma, C. H. Y., Lin, J., ... & Kwong, K. W. Y. (2022). Safety and immunogenicity of inactivated Bacillus subtilis spores as a heterologous antibody booster for COVID-19 vaccines. Vaccines, 10(7), 1014. https://doi.org/10.3390/ vaccines10071014 Tizard, I. R. (2020). The administration of vaccines. Vaccines For Veterinarians, 87. https://doi.org/10.1016/B978-0-323-68299- 2.00017-4 Verma, S. K., Mahajan, P., Singh, N. K., Gupta, A., Aggarwal, R., Rappuoli, R., & Johri, A. K. (2023). New-age vaccine adjuvants, their development, and future perspective. Frontiers in Immunology, 14, 1043109. https://doi.org/10.3389/fimmu.2023.1043109 Vos, A., Freuling, C., Ortmann, S., Kretzschmar, A., Mayer, D., Schliephake, A., & Müller, T. (2018). An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non- target species. Vaccine, 36(6), 811-817. https://doi.org/10.1016/j. vaccine.2017.12.076 Wen, H., Jung, H., & Li, X. (2015). Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. The AAPS Journal, 17, 1327-1340. https://doi.org/10.1208/s12248- 015-9814-9 Xu, B., Zhang, W., Chen, Y., Xu, Y., Wang, B., & Zong, L. (2018). Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery. International Journal of Biological Macromolecules, 113, 534-542. https://doi.org/10.1016/j.ijbiomac.2018.02.016 Zhang, Y., Li, M., Du, G., Chen, X., & Sun, X. (2021). Advanced oral vaccine delivery strategies for improving the immunity. Advanced Drug Delivery Reviews, 177, 113928. https://doi.org/10.1016/j. addr.2021.113928 Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023). Vaccine adjuvants: mechanisms and platforms. Signal Transduction and Targeted Therapy, 8(1), 283. https://doi.org/10.1038/s41392-023- 01557-7 Zhao, T., Li, J., Fu, Y., Ye, H., Liu, X., Li, G., ... & Yang, J. (2020). Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine. Npj Vaccines, 5(1), 47. https://doi.org/10.1038/s41541- 020-0194-5 Zhong, K., Chen, X., Zhang, J., Jiang, X., Zhang, J., Huang, M., ... & Luo, Y. (2024). Recent Advances in Oral Vaccines for Animals. Veterinary Sciences, 11(8), 353. https://doi.org/10.3390/vetsci11080353 Zimmermann, P., & Curtis, N. (2019). Factors that influence the immune response to vaccination. Clinical Microbiology Reviews, 32(2), 10- 1128. https://doi.org/10.1128/cmr.00084-18